Cargando…
Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: perihilar cholangiocarcinoma versus distal bile duct cancer
PURPOSE: Extrahepatic cholangiocarcinoma is distinguished into perihilar cholangiocarcinoma (PHC) and distal bile duct cancer (DBC). The studies for each subtype have been conducted separately. This study compared oncological outcomes between PHC and DBC. METHODS: From 2001 to 2017, patients who und...
Autores principales: | Lee, Jung Min, Kim, Hongbeom, Sohn, Hee Ju, Choi, Yoo Jin, Kang, Jae Seung, Han, Youngmin, Kwon, Wooil, Jang, Jin-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Surgical Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831089/ https://www.ncbi.nlm.nih.gov/pubmed/35198513 http://dx.doi.org/10.4174/astr.2022.102.2.100 |
Ejemplares similares
-
Galanin System in the Human Bile Duct and Perihilar Cholangiocarcinoma
por: Huber, Sara, et al.
Publicado: (2023) -
Bacterial bile duct colonization in perihilar cholangiocarcinoma and its clinical significance
por: Bednarsch, Jan, et al.
Publicado: (2021) -
Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer
por: Kim, Hyeong Seok, et al.
Publicado: (2021) -
Predicting prognosis and evaluating the benefits of adjuvant chemotherapy depending on the tumor location in intrahepatic cholangiocarcinoma: focusing on the involvement of below 2nd bile duct confluence
por: Sohn, Hee Ju, et al.
Publicado: (2022) -
Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma
por: Zhang, DengYong, et al.
Publicado: (2023)